Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. A | 27 | 1 | 4 | 0 | €166.60 | €196.17 | 17.747% |
| Zealand Pharma A/s | 1 | 0 | 0 | 0 | €125.70 | - | - |
| XOMA Corp. | 9 | 0 | 1 | 0 | €23.60 | €68.62 | 190.764% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 1 | 0 | €2.44 | €4.39 | 80.267% |
| WAVE Life Sciences Ltd | 7 | 0 | 0 | 0 | €5.30 | €14.91 | 181.243% |
| Viatris Inc. | 2 | 0 | 1 | 0 | €10.59 | €12.50 | 18.036% |
| Vertex Pharmaceuticals Inc. | 60 | 2 | 11 | 0 | €433.10 | €450.36 | 3.986% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €40.80 | - | - |
| Verastem Inc. | 16 | 0 | 5 | 0 | €2.14 | €16.20 | 657.164% |
| Veracyte Inc. | 1 | 0 | 0 | 0 | €28.20 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.72 | €8.52 | 80.585% |
| Valneva SE | 1 | 0 | 0 | 0 | €3.42 | - | - |
| United Therapeutics | 25 | 1 | 5 | 1 | €291.10 | €294.38 | 1.126% |
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 5 | 0 | €47.00 | €84.74 | 80.306% |
| UCB S.A. | 1 | 0 | 0 | 0 | €153.85 | - | - |
| Twist Bioscience Corp | 13 | 2 | 2 | 2 | €39.53 | €41.76 | 5.641% |
| Trinity Biotech ADR | 26 | 0 | 1 | 0 | €0.41 | - | - |
| TG Therapeutics Inc. | 20 | 2 | 2 | 0 | €20.03 | €31.12 | 55.385% |
| Teva Pharmaceutical Industries Ltd ADR | 19 | 0 | 2 | 0 | €16.60 | €19.34 | 16.499% |
| Taro Pharmaceutical Industries Ltd | 9 | 0 | 0 | 0 | €40.00 | - | - |
| Sutro Biopharma Inc | 21 | 0 | 2 | 0 | €3.22 | €11.04 | 242.932% |
| Stoke Therapeutics Inc | 14 | 1 | 1 | 0 | €13.00 | €20.33 | 56.412% |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.65 | - | - |
| SCYNEXIS Inc. | 4 | 0 | 0 | 0 | €1.51 | €2.28 | 50.962% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €121.10 | €130.00 | 7.349% |